Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.5 USD | -0.26% |
|
+8.22% | +50.46% |
03/07 | Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added to S&P 1000 | CI |
03/07 | Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added to S&P 600 Health Care | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.46% | 202.35Cr | |
+16.59% | 4.44TCr | |
+41.02% | 3.98TCr | |
-10.62% | 3.77TCr | |
+29.92% | 3.15TCr | |
-9.23% | 2.7TCr | |
+12.34% | 2.63TCr | |
+41.53% | 1.38TCr | |
+31.49% | 1.25TCr | |
-7.40% | 1.13TCr |
- Stock Market
- Equities
- PTGX Stock
- News Protagonist Therapeutics, Inc.
- Transcript : Protagonist Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-11-2021 11